Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    19696651 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Lamivudine;   Drug: Stavudine
2 Not yet recruiting Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Condition: HIV
Intervention: Biological: HXTC infusion
3 Recruiting A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
Condition: HIV
Intervention: Biological: AGS-004

Indicates status has not been verified in more than two years